DnIKK2-transfected dendritic cells induce a novel population of inducible nitric oxide synthase-expressing CD4+CD25- cells with tolerogenic properties

Transplantation

Volumn 83, Issue 4, 2007, Pages 474-484

  Aiello, Sistiana ^a   Cassis, Paola ^a   Cassis, Linda ^a   Tomasoni, Susanna ^a   Benigni, Ariela ^a   Pezzotta, Anna ^a   Cavinato, Regiane A ^a   Cugini, Daniela ^a   Azzollini, Nadia ^a   Mister, Marilena ^a   Longaretti, Lorena ^a   Thomson, Angus W ^b   Remuzzi, Giuseppe ^a,c   Noris, Marina ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c OSPEDALI RIUNITI   (Italy)

Author keywords

Dendritic cells; Inducible nitric oxide synthase; Rat kidney allotransplantation; T regulatory cells

Indexed keywords

ADENOVIRUS VECTOR; ALLOANTIGEN; GAMMA INTERFERON; I KAPPA B KINASE; I KAPPA B KINASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 2; NEUTRALIZING ANTIBODY; NITRIC OXIDE SYNTHASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; IKK2 PROTEIN, RAT; INTERLEUKIN 2 RECEPTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; BROWN NORWAY RAT; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CELL CULTURE; CELL FUNCTION; CELL INTERACTION; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; DRUG MECHANISM; DRUG POTENCY; ENZYME MECHANISM; ENZYME RELEASE; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSFECTION; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VIVO STUDY; KIDNEY ALLOGRAFT; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LEWIS RAT; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURIFICATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; RENAL GRAFT DYSFUNCTION; SURVIVAL TIME; ALLOTRANSPLANTATION; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; SOLUBILITY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; GRAFT SURVIVAL; I-KAPPA B KINASE; IMMUNE TOLERANCE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KIDNEY TRANSPLANTATION; NITRIC OXIDE SYNTHASE TYPE II; PHENOTYPE; RATS; SOLUBILITY; TRANSPLANTATION, HOMOLOGOUS;

EID: 33947538039     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000251808.91901.c3     Document Type: Article

References (47)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392.
2. Steinman RM, Nussenzweig MC. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A 2002; 99: 351.
3. Moser M. Dendritic cells in immunity and tolerance-do they display opposite functions? Immunity 2003; 19: 5.
4. Morelli AE, Thomson AW. Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev 2003; 196: 125.
5. Wakkach A, Fournier N, Brun V, et al. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003; 18: 605.
6. -) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996; 62: 659.
7. Lutz MB, Suri RM, Niimi M, et al. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 2000; 30: 1813.
8. Roelen DL, Schuurhuis DH, van den Boogaardt DE, et al. Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells. Transplantation 2003; 76: 1608.
9. Taner T, Hackstein H, Wang Z, et al. Rapamycin-treated, alloantigen-pulsed host dendritic cells induced Ag-specific T cell regulation and prolong graft survival. Am J Transpl 2005; 5: 228.
10. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000; 192: 1213.
11. Sato K, Yamashita N, Baba M, Matsuyama T. Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood 2003; 101: 3581.
12. Mirenda V, Berton I, Read J, et al. Modified dendritic cells coexpressing self and allogeneic major histocompatibility complex molecules: an efficient way to induce indirect pathway regulation. J Am Soc Nephrol 2004; 15: 987.
13. Tan PH, Sagoo P, Chan C, et al. Inhibition of NF-kB and oxidative pathway human dendritic cells by antioxidative vitamins generates regulatory T cells. J Immunol 2005; 174: 7633.
14. Yoshimura S, Bondeson J, Foxwell BM, et al. Effective antigen presentation by dendritic cells is NF-kappa B dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines. Int Immunol 2001; 13: 675.
15. Giannoukakis N, Bonham CA, Qian S, et al. Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides. Mol Ther 2000; 1: 430.
16. Karin M, Yamamoto Y, Wang QM. The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov 2004; 3: 17.
17. Andreakos E, Smith C, Monaco C, et al. Ikappa B kinase 2 but not NF-kappa B-inducing kinase is essential for effective DC antigen presentation in the allogeneic mixed lymphocyte reaction. Blood 2003; 101: 983.
18. + T-regulatory cells. Transplantation 2005; 79: 1056.
19. Benigni A, Zoja C, Corna D, et al. Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat. J Am Soc Nephrol 2003; 14: 1816.
20. Dasch JR, Pace DR, Waegell W, et al. Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification. J Immunol 1989; 142: 1536.
21. Talmor M, Mirza A, Turley S, et al. Generation of large numbers of immature and mature dendritic cells from rat bone marrow cultures. Eur J Immunol 1998; 28: 811.
22. Cavinato R, Casiraghi F, Azzollini N, et al. Pretransplant donor peripheral blood mononuclear cell infusion induces tranplantation tolerance by generating regulatory T cells. Tranplantation 2005; 79: 1034.
23. Noris M, Cugini D, Casiraghi F, et al. Thymic microchimerism correlates with the outcome of tolerance-inducing protocols for solid organ transplantation. J Am Soc Nephrol 2001; 12: 2815.
24. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199.
25. Van der Veen RC. Nitric oxide and T helper cell immunity. Int Immunopharmacol 2001; 1: 1491.
26. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 2004; 10: 801.
27. + Tregs. J Clin Invest 2005; 115: 2904.
28. + T lymphocytes. PNAS 2005; 102: 11817.
29. + regulatory T cells from nonobese diabetic mice. J Immunol 2005; 175: 3053.
30. + regulatory T cells. Blood 2005; 105: 4743.
31. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 2004; 199: 1467.
32. - T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance. Transplantation 2005; 79: 1308.
33. + suppressor T cells. J Exp Med 2001; 193: F41.
34. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000; 101: 455.
35. + regulatory T cells. Curr Opin Immunol 2004; 16: 203.
36. Weiner HL. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 2001; 182: 207.
37. Roncarolo MG, Bacchetta R, Bordignon C, et al. Type 1 T regulatory cells. Immunol Rev 2001; 182: 68.
38. Min WP, Zhou D, Ichim TE, et al. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol 2003; 170: 1304.
39. Bacchetta R, Sartirana C, Levings MK, et al. Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines. Eur J Immunol 2002; 32: 2237.
40. Groux H. An overview of regulatory T cells. Microbes Infect 2001; 3: 883.
41. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389: 737.
42. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002; 195: 603.
43. McGuirk P, McCann C, Mills KH. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulate interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med 2002; 195: 221.
44. + cells that require antigen-specific activation for suppression. J Immunol 2003; 171: 6431.
45. + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003; 421: 388.
46. Kahl KG, Schmidt HH, Jung S, et al. Experimental autoimmune encephalomyelitis in mice with a targeted deletion on the inducible nitric oxide synthase gene: increased T-helper 1 response. Neurosci Lett 2004; 358: 58.
47. Gabbai FB, Boggiano C, Peter T. Inhibition of inducible nitric oxide synthase intensifies injury and functional deterioration in autoimmune interstitial nephritis. J Immunol 1997; 159: 626.